Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prediction Using Diffusion-weighted MRI of the Response Evaluation in Borderline Resectable Pancreatic Cancer.

NCT02777463 is registered in ClinicalTrials.gov with Wakayama Medical University as lead sponsor.

NCT NCT02777463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02777463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prediction Using Diffusion-weighted MRI of the Response Evaluation in Borderline Resectable Pancreatic Cancer.
Lead sponsor
Wakayama Medical University
Phase
Observational
Overall status
Completed
Start date
June 30, 2016
Completion date
January 31, 2020
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer